Search Results - "Naughton, John"

Refine Results
  1. 1

    In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation by Moreno, Ana M., Fu, Xin, Zhu, Jie, Katrekar, Dhruva, Shih, Yu-Ru V., Marlett, John, Cabotaje, Jessica, Tat, Jasmine, Naughton, John, Lisowski, Leszek, Varghese, Shyni, Zhang, Kang, Mali, Prashant

    Published in Molecular therapy (05-07-2018)
    “…Development of efficacious in vivo delivery platforms for CRISPR-Cas9-based epigenome engineering will be critical to enable the ability to target human…”
    Get full text
    Journal Article
  2. 2

    Lecture: Getting from here to there by Naughton, John

    Published in MedieKultur (19-12-2014)
    “…Based on his keynote lecture at the international conference on Digital Humanities at Aalborg University in April 2014, John Naughton refl ects on being an…”
    Get full text
    Journal Article
  3. 3

    Effect of Nasal Valve Shape on Downstream Volume, Airflow, and Pressure Drop: Importance of the Nasal Valve Revisited by Naughton, John P., Lee, Andrew Y., Ramos, Eric, Wootton, David, Stupak, Howard D.

    Published in Annals of otology, rhinology & laryngology (01-11-2018)
    “…Objectives: The relative importance of the nasal valve relative to the remainder of the nasal airway remains unknown. The goal of this article was to…”
    Get full text
    Journal Article
  4. 4

    Identification of a 3-aminoimidazo[1,2-a]pyridine inhibitor of HIV-1 reverse transcriptase by Elleder, Daniel, Baiga, Thomas J, Russell, Rebecca L, Naughton, John A, Hughes, Stephen H, Noel, Joseph P, Young, John A T

    Published in Virology journal (11-12-2012)
    “…Despite the effectiveness of highly active antiretroviral therapy (HAART), there remains an urgent need to develop new human immunodeficiency virus type 1…”
    Get full text
    Journal Article
  5. 5

    Differential protein stability of EGFR mutants determines responsiveness to tyrosine kinase inhibitors by Ray, Paramita, Tan, Yee Sun, Somnay, Vishal, Mehta, Ranjit, Sitto, Merna, Ahsan, Aarif, Nyati, Shyam, Naughton, John P, Bridges, Alexander, Zhao, Lili, Rehemtulla, Alnawaz, Lawrence, Theodore S, Ray, Dipankar, Nyati, Mukesh K

    Published in Oncotarget (18-10-2016)
    “…Non-small cell lung cancer (NSCLC) patients carrying specific EGFR kinase activating mutations (L858R, delE746-A750) respond well to tyrosine kinase inhibitors…”
    Get full text
    Journal Article
  6. 6

    Imaging single retrovirus entry through alternative receptor isoforms and intermediates of virus-endosome fusion by Jha, Naveen K, Latinovic, Olga, Martin, Erik, Novitskiy, Gennadiy, Marin, Mariana, Miyauchi, Kosuke, Naughton, John, Young, John A T, Melikyan, Gregory B

    Published in PLoS pathogens (01-01-2011)
    “…A large group of viruses rely on low pH to activate their fusion proteins that merge the viral envelope with an endosomal membrane, releasing the viral…”
    Get full text
    Journal Article
  7. 7

    Poststroke rehabilitation : Outcomes and reimbursement of inpatient rehabilitation facilities and subacute rehabilitation programs by DEUTSCH, Anne, GRANGER, Carl V, HEINEMANN, Allen W, FIEDLER, Roger C, DEJONG, Gerben, KANE, Robert L, OTTENBACHER, Kenneth J, NAUGHTON, John P, TREVISAN, Maurizio

    Published in Stroke (1970) (01-06-2006)
    “…To assess whether poststroke rehabilitation outcomes and reimbursement for Medicare beneficiaries differ across inpatient rehabilitation facilities (IRFs) and…”
    Get full text
    Journal Article
  8. 8

    Delayed toxicity associated with soluble anthrax toxin receptor decoy-Ig fusion protein treatment by Thomas, Diane, Naughton, John, Cote, Christopher, Welkos, Susan, Manchester, Marianne, Young, John A T

    Published in PloS one (12-04-2012)
    “…Soluble receptor decoy inhibitors, including receptor-immunogloubulin (Ig) fusion proteins, have shown promise as candidate anthrax toxin therapeutics. These…”
    Get full text
    Journal Article
  9. 9

    Outcomes and Reimbursement of Inpatient Rehabilitation Facilities and Subacute Rehabilitation Programs for Medicare Beneficiaries with Hip Fracture by Anne Deutsch, Granger, Carl V., Roger C. Fiedler, DeJong, Gerben, Kane, Robert L., Ottenbacher, Kenneth J., Allen W. Heinemann, John P. Naughton, Trevisan, Maurizio

    Published in Medical care (01-09-2005)
    “…Objective: We sought to assess whether outcomes and reimbursement differ for Medicare beneficiaries with hip fracture when treated in an inpatient…”
    Get full text
    Journal Article
  10. 10

    CAR1, a TNFR–Related Protein, Is a Cellular Receptor for Cytopathic Avian Leukosis–Sarcoma Viruses and Mediates Apoptosis by Brojatsch, Jürgen, Naughton, John, Rolls, Melissa M, Zingler, Kurt, Young, John A.T

    Published in Cell (29-11-1996)
    “…Viral envelope (Env)–receptor interactions have been implicated in the cell death associated with infection by subgroups B and D avian leukosis–sarcoma viruses…”
    Get full text
    Journal Article
  11. 11

    The 'interest' based penalty tests in 'Paciocco' and 'Cavendish/Parkingeye' and the law of penalties and damages in Australia and the United Kingdom by John Naughton, Larissa Welmans

    Published in University of Western Australia law review (01-08-2018)
    “…This article maps the current penalty tests in Australia and the United Kingdom following recent revision. It demonstrates how this revision has relaxed the…”
    Get full text
    Journal Article
  12. 12

    Identification of a cellular receptor for subgroup E avian leukosis virus by Adkins, H.B, Brojatsch, J, Naughton, J, Rolls, M.M, Pesola, J.M, Young, J.A.T

    “…Genetic studies in chickens and receptor interference experiments have indicated that avian leukosis virus (ALV)-E may utilize a cellular receptor related to…”
    Get full text
    Journal Article
  13. 13
  14. 14

    TVB Receptors for Cytopathic and Noncytopathic Subgroups of Avian Leukosis Viruses Are Functional Death Receptors by Brojatsch, J, Naughton, J, Adkins, H B, Young, J A

    Published in Journal of Virology (01-12-2000)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  15. 15

    Lecture: Getting from here to there by John Naughton

    Published in MedieKultur (01-12-2014)
    “…Based on his keynote lecture at the international conference on Digital Humanities at Aalborg University in April 2014, John Naughton refl ects on being an…”
    Get full text
    Journal Article
  16. 16

    Enveloped Viruses Disable Innate Immune Responses in Dendritic Cells by Direct Activation of TAM Receptors by Bhattacharyya, Suchita, Zagórska, Anna, Lew, Erin D., Shrestha, Bimmi, Rothlin, Carla V., Naughton, John, Diamond, Michael S., Lemke, Greg, Young, John A.T.

    Published in Cell host & microbe (14-08-2013)
    “…Upon activation by the ligands Gas6 and Protein S, Tyro3/Axl/Mer (TAM) receptor tyrosine kinases promote phagocytic clearance of apoptotic cells and…”
    Get full text
    Journal Article
  17. 17

    Work and Leisure Time Physical Activity and Mortality in Men and Women from a General Population Sample by Dorn, Joan P, Cerny, Frank J, Epstein, Leonard H, Naughton, John, Vena, John E, Winkelstein, Warren, Schisterman, Enrique, Trevisan, Maurizio

    Published in Annals of epidemiology (01-08-1999)
    “…PURPOSE: The purpose of this study was to examine the long-term relationships between total physical activity and mortality from all causes and coronary heart…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Recombinant Viral Vectors as Neuroscience Tools by Chen, Shih-Heng, Haam, Juhee, Walker, Mitzie, Scappini, Erica, Naughton, John, Martin, Negin P

    Published in Current protocols in neuroscience (01-04-2019)
    “…Recombinant viruses are highly efficient vehicles for in vivo gene delivery. Viral vectors expand the neurobiology toolbox to include direct and rapid…”
    Get more information
    Journal Article